Matthias M. Herth

University of Copenhagen — Denmark

Medicine · Health Sciences

30h-index3.2kcitations233works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Radiopharmaceutical Chemistry and Applications(78), Click Chemistry and Applications(58), Medical Imaging Techniques and Applications(51), Monoclonal and Polyclonal Antibodies Research(32), Chemical Synthesis and Analysis(30)

Publications233 total

In Vivo Comparison of Site-Specific and Site-Selective Methods for Pretargeted Imaging in a Murine Model of Colorectal Cancer
Molecular Pharmaceutics·2026
Friedel–Crafts-Type Electrophilic Radiocyanation of (Hetero)arenes
Organic Letters·2026
FLIM-FRET Imaging of AMPA Receptors: New Principle for Subtype-Specific Elucidation
2025Open Access
Pretargeted Immuno-PET Enables Monoclonal Antibody Imaging Beyond the Blood–Brain Barrier
Molecular Pharmaceutics·2025Open Access
Development of 11C-Phenethylamine Analogues as novel PET Tracers for the Imaging of 5-HT2A Receptor Biased Agonism
Nuclear Medicine and Biology·2025
Initial Investigations into Nanobody Functionalization and Radiolabeling with Astatine-211
Nuclear Medicine and Biology·2025Open Access
Delivery of the Auger Therapeutic [125I]IUdR via Nanocarriers for Treatment of Glioblastoma
Nuclear Medicine and Biology·2025
Visualization of the CaMKIIα hub domain with 18F-labeled PET tracers
Nuclear Medicine and Biology·2025
Small molecular scaffolds toward in vivo stable Astatine-211 radiopharmaceuticals
Nuclear Medicine and Biology·2025
Development of Theranostics Targeting the Neuropeptide Y Receptors
Nuclear Medicine and Biology·2025
Design of innovative FAP-target modules for simultaneous delivery of CAR-T cell-and radiotherapy
Nuclear Medicine and Biology·2025Open Access
The Synthesis and In Vivo Evaluation of a Lysosome-Targeting Chimera for the Clearance of Bloodstream Antibodies
Nuclear Medicine and Biology·2025Open Access
Brain Pretargeted PET – New Horizons to Image CNS Targets with Monoclonal Antibodies
Nuclear Medicine and Biology·2025
Development of a stable pretargeting platform for immuno-PET imaging
Nuclear Medicine and Biology·2025Open Access
Comparison of Organometallics Towards Electrophilic Aromatic 211At-Astatinations of Tetrazines and Application in Pretargeted Therapy
Nuclear Medicine and Biology·2025Open Access
Development of peptide probes for astatine-211 based uPAR targeted radionuclide therapy
Nuclear Medicine and Biology·2025
Copper-Mediated 11C-Radiocyanation of Aryl Germatranes
Nuclear Medicine and Biology·2025
Electrophilic 11C-Radiocyanation of Arenes
Nuclear Medicine and Biology·2025
Astatine‐211—Towards In Vivo Stable Astatine‐211 Labeled Radiopharmaceuticals and Their (Pre)Clinical Applications
Medicinal Research Reviews·2025· 4 citedOpen Access
Preliminary First-in-Human Pharmacokinetic Evaluation, Dosimetry and Safety of 7-[ <sup>18</sup> F]-Fluorotryptophan as PET Imaging Agent to Visualize Serotonin Synthesis in the Brain
2025Open Access
page 1 of 12Next →

Frequent Co-authors

Vladimir Shalgunov(18), Gitte M. Knudsen(18), Andreas Kjær(12), Jesper L. Kristensen(12), Jesper Tranekjær Jørgensen(9), Szabolcs Lehel(9), Umberto Maria Battisti(9), Anders Ettrup(8), Hanne D. Hansen(8), Frank Rösch(8), Patricia E. Edem(7), Mikael Palner(7), Hannes Mikula(7), Nic Gillings(6), Rocío García‐Vázquez(6), Kamilla Nørregaard(5), Matthias Barz(5), Klas Bratteby(5), Lars Hvass(5), Markus Piel(5)